Astrazeneca Drug Boost, UK Supermarkets, Travis Perkins Falls
On this episode of Stock Movers:- AstraZeneca's experimental cholesterol drug significantly reduced “bad” cholesterol in a mid-stage trial, boosting hopes for a potential blockbuster that could be part of a powerful combination medicine targeting weight loss and related ailments. The once-a-day pill led to a 50.7% reduction in low-density lipoprotein cholesterol, often called LDL, when given on top of statins, according to data presented at the American College of Cardiology in Chicago.- UK supermarket stocks decline as analysts cut profit estimates following a recent profit…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.